跳至主要内容
临床试验/EUCTR2018-004300-19-FR
EUCTR2018-004300-19-FR进行中(未招募)1 期

Target-controled infusion with propofol in the Emergency Department : a prospective study on 50 adult patients - SIVOC

CHU DE NICE0 个研究点目标入组 50 人开始时间: 2018年12月14日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
CHU DE NICE
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Age of 18 or more
  • Affiliated or beneficiary of a French health insurance system
  • Indication of procedural sedation by the emergency department physician in the context of the management of a patient with an orthopedic lesion requiring a potentially painful emergency therapeutic action (reduction of a joint dislocation or realignment of a limb displaced fracture)
  • Signed free informed consent or inclusion in the context of an emergency situation
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 50
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 50

排除标准

  • Patient of more than 18 under legal protection or deprivation of liberty measures
  • Ongoing pregnancy or breastfeeding women
  • Patient with the incapacity to give his free informed consent, excepted if the incapacity is induced by the context of the emergency situation (inclusion in the context of an emergency situation)
  • Known hypersensitivity to propofol or one of the excipients, egg, soja or peanuts
  • ASA comorbidity score of 4 or more
  • Heart, respiratory, renal or hepatic failure
  • Lipid metabolism disorder
  • Mitochondrial disease
  • Hemodynamic instability, multiple traumatism
  • Elevated intracranial tension
  • Drug or alcohol intoxication

研究者

发起方
CHU DE NICE

相似试验